Armata Pharmaceuticals
Develops bacteriophage cocktails for serious antibiotic-resistant bacterial infections.
$5.37
After-hours close+0.05 (+0.94%)
At close$5.32(−2.03%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.57 | — | — |
| Aug 2026 | −$0.45 | −$0.27 | +39.3% |
| Aug 2026 | −$0.48 | −$0.27 | +43.7% |
| May 2026 | −$0.38 | −$3.16 | −731.6% |
| Mar 2026 | −$0.19 | −$0.51 | −168.4% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$0.57 | — | — | $450.0K | — | — |
| Aug 12, 2026 | −$0.45 | −$0.27 | +39.3% | $400.0K | $2.5M | +527.5% |
| Aug 11, 2026 | −$0.48 | −$0.27 | +43.7% | $400.0K | — | — |
| May 13, 2026 | −$0.38 | −$3.16 | −731.6% | $740.0K | $789.0K | +6.6% |
| Mar 25, 2026 | −$0.19 | −$0.51 | −168.4% | $740.0K | $1.1M | +48.6% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Nov 12, 2025 | ||||||
| Aug 12, 2025 | ||||||
| May 14, 2025 | ||||||
| Mar 20, 2025 | ||||||
| Nov 13, 2024 | ||||||
| Aug 13, 2024 | ||||||
| May 7, 2024 | ||||||
| Mar 21, 2024 | ||||||
| Nov 14, 2023 | ||||||
| Aug 14, 2023 | ||||||
| May 11, 2023 | ||||||
| Mar 16, 2023 | ||||||
| Nov 9, 2022 | ||||||
| Aug 11, 2022 | ||||||
| May 12, 2022 | ||||||
| Mar 17, 2022 | ||||||
| Nov 10, 2021 | ||||||
| Aug 12, 2021 | ||||||
| May 13, 2021 | ||||||
| Mar 18, 2021 | ||||||
| Nov 12, 2020 | ||||||
| Aug 13, 2020 | ||||||
| May 14, 2020 | ||||||
| Mar 19, 2020 | ||||||
| Nov 12, 2019 | ||||||
| Aug 14, 2019 | ||||||
| May 6, 2019 | ||||||
| Mar 25, 2019 | ||||||
| Nov 8, 2018 | ||||||
| Aug 9, 2018 | ||||||
| May 15, 2018 | ||||||
| Mar 14, 2018 | ||||||
| Nov 14, 2017 | ||||||
| Aug 14, 2017 | ||||||
| May 15, 2017 | ||||||
| Mar 27, 2017 | ||||||
| Nov 10, 2016 | ||||||
| Aug 15, 2016 | ||||||
| May 12, 2016 | ||||||
| Mar 30, 2016 | ||||||
| Nov 16, 2015 | ||||||